Four major molecular subtypes of breast cancer have been identified by comprehensive gene expression profiling, including luminal A, luminal B, human epidermal growth factor receptor-2 (HER2) positive, and TNBC, which are described by specific biological features, morphological patterns, and most significantly, distinct clinical processes and prognoses [7,8]. Here, ERBB2 is linked to breast cancer.